Drug Profile
Heparinoid - Maruho
Alternative Names: M-118102Latest Information Update: 26 Oct 2020
Price :
$50
*
At a glance
- Originator Maruho
- Class Anti-inflammatories; Anticoagulants; Glycosaminoglycans; Heparins; Skin disorder therapies
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Sebaceous gland disorders
Most Recent Events
- 26 Oct 2020 No development reported - Phase-III for Sebaceous gland disorders in Japan (Topical)